Contrarian Sales Techniques

DECEMBER 14, 2022

Bright Prospects Indicates by Zacks Industry Rank The large-cap pharmaceutical industry, which is a part of the Medical sector, has a favorable Industry rank of A. The company, which is a global healthcare company, operates through different divisions such as pharmaceuticals, medical devices, and consumer products. in 2023. **The

Food and Drug Administration 52

Food and Drug Administration Pharmaceutical Sales Medicine 52

Legacy MEDSearch

JUNE 22, 2023

Food and Drug Administration (FDA) clearance to use the Topcon NW400 retinal camera with its EyeArt AI system to automatically detect diabetic retinopathy (DR), adding to the already-cleared usage with Canon CR-2 AF and Canon CR-2 Plus AF cameras. ” This latest FDA clearance for the EyeArt v2.2.0 sensitivity and 91.1%

FDA 52

FDA Food and Drug Administration Recruitment Marketing 52

Legacy MEDSearch

MAY 1, 2023

The results were featured in the late-breaking session ( LBA01-05 ) at the American Urological Association (AUA) 2023 Annual Meeting in Chicago on Sunday, April 30 th. Results from the trial are under review by the FDA. We continue to work with the FDA and look forward to introducing this innovative solution to physicians and patients.”

Patients 52

Patients Medical Safety Recruitment 52

Pharmaceutical Technology

MARCH 17, 2023

But while appealing, the prospects of developing a merged approach that combines both digital and pharmacological therapeutics remain challenging. In the US, a group of lawmakers recently reintroduced the “Access to Prescription Digital Therapeutics Act of 2023” in the US Senate.

Prescription 111

Prescription Pharmacology Pharma Medical 111

European Pharmaceutical Review

APRIL 30, 2024

Vikas Gupta (VG): In the years preceding the Covid pandemic, the ATMP s market, including both the innovators as well as the contract development and manufacturing organisations (CDMOs), was a bit too optimistic about its growth prospects as it was building significant manufacturing capacity focusing primarily on viral vectors.

Manufacturing 78

Manufacturing Food and Drug Administration Biopharma Marketing 78

Pharmaceutical Technology

JULY 4, 2022

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

Pharma 122

Pharma Food and Drug Administration Manufacturing Medicine 122

Evolve Your Success

APRIL 11, 2023

There’s less patient pain and ultimately less cost for the healthcare facility. We have launched into the US marketplace and got the product design through FDA. We had some great responses because it solves some problems on the clinician side, the patient side and the healthcare provider side. I’ve got an FDA issue.”

Sales 52

Sales Medical Medical sales Media 52

Pharmaceutical Technology

DECEMBER 4, 2022

There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January. Indeed, Amgen’s biosimilar was approved in September 2016, but the company was not able to launch it until January 2023 in the US. While small molecule drugs can be remade into identical generics, biologics are more complex.

Marketing 104

Marketing Physicians Competition Patients 104

Pharmaceutical Technology

MAY 24, 2023

Innoviva has snagged a win for its bacterial pneumonia drug Xacduro (durlobactam sodium + sulbactam) with a US Food and Drug Administration FDA approval for use in patients of ages 18 or older. The FDA approval stemmed from results from Entasis’ Phase III Attack trial (NCT03894046).

FDA 52

FDA Food and Drug Administration Patients Prospecting 52

Pharmaceutical Technology

MARCH 21, 2023

FDA and EMA decisions In January, the European Commission (EC) approved Roche’s Xofluza (baloxavir marboxil) to prevent and treat influenza in children ages one year and older. Regulatory decisions by the FDA and EMA for select therapies from late January to late February and the CMOs contracted to manufacture the therapies.

Manufacturing 59

Manufacturing Pharmaceutical Biopharma FDA 59

Pharmaceutical Technology

MAY 26, 2023

The FDA has flagged this issue as pharmacies selling prescription drugs illegally have proliferated over the years. The US Food and Drug Administration (FDA commissioner Dr. Robert Califf says, “The illegal sale of prescription drug stimulants online puts Americans at risk and contributes to potential abuse, misuse, and overdose.”

Food and Drug Administration 52

Food and Drug Administration Prescription FDA Medical 52

Pharmaceutical Technology

FEBRUARY 6, 2023

In the midst of tough predictions for 2023 due to inflation and a difficult funding environment, Pliant Therapeutics closed an oversubscribed $287.5 Leading up to 2023, experts have said a company’s financial wellbeing may depend on its economic position when the market shifted. The FDA approved both drugs in 2014.

Marketing 59

Marketing Pharmaceutical FDA Prospecting 59

Pharmaceutical Technology

JANUARY 6, 2023

Last year, Novartis began with a win in January, as the US Court of Appeals affirmed the validity of Gilenya’s patent, allowing the company to sue a competitor generics company for filing for FDA approval for its Gilenya generic. In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

JANUARY 15, 2023

In the first 2023 edition of the CMO Moves monthly series , Pharmaceutical Technology explores recent news stories on regulatory and reimbursement decisions in different countries, and the companies linked to their success and failures. FDA expands approval labels. Source: GlobalData Pharmaceutical Intelligence Center.

Manufacturing 52

Manufacturing Pharmaceutical FDA Pharma 52